Hyperstable miniproteins can be _de novo_ designed to tightly bind protein targets, a promising new avenue for treating infectious disease. Pioneering work by Chevalier et al…
Pioneering work from the Baker lab at University of Washington has resulted in _de novo_ designed miniproteins that bind the H1N1 hemagglutinin stem protein (HA2), exemplifying a promising new avenue for treating infectious disease…